New England Journal of Medicine

mineralys-therapeutics-moves-forward-with-hypertension-drug-filing

Mineralys Therapeutics Moves Forward with Hypertension Drug Filing

Editorial 16 August, 2025

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has reported a series of significant clinical advancements and...

once-weekly-efsitora-offers-new-hope-for-type-2-diabetes-management

Once-Weekly Efsitora Offers New Hope for Type 2 Diabetes Management

Editorial 14 July, 2025

Eli Lilly’s once-weekly insulin formulation, efsitora, has demonstrated comparable efficacy to daily insulin glargine...